Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease

Bacillus Calmette-Guérin (BCG) remains the most effective intravesical therapy for non-muscle invasive bladder cancer but will fail in up to 40% of patients. The ability to identify patients who are least likely to respond to further BCG therapy allows urologists to pursue secondary treatments more...

Full description

Saved in:
Bibliographic Details
Published in:Bl Cancer
Main Authors: Steinberg, Ryan L., Thomas, Lewis J., O’Donnell, Michael A.
Format: Artigo
Language:Inglês
Published: IOS Press 2015
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4927833/
https://ncbi.nlm.nih.gov/pubmed/27376112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-150015
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items